Acoustic Dispensing Preserves the Potency of Therapeutic Peptides throughout the Entire Drug Discovery Workflow

Journal of Laboratory Automation

Volumn 21, Issue 1, 2016, Pages 90-96

  Naylor, Jacqueline ^a   Rossi, Alessandra ^a   Hornigold, David C ^a  

^a MEDIMMUNE   (United States)

Author keywords

acoustic droplet ejection; cAMP; EC50; GLP 1; glucagon

Indexed keywords

BIOCHEMISTRY; BODY FLUIDS; DROPS; DRUG PRODUCTS; SCREENING;

ACOUSTIC DROPLET EJECTIONS; CAMP; EC50; GLP-1; GLUCAGON;

PEPTIDES;

CYCLIC AMP; DIMETHYL SULFOXIDE; GLUCAGON; GLUCAGON LIKE PEPTIDE; GLUCAGON LIKE PEPTIDE 1; PEPTIDE; SOLUTION AND SOLUBILITY;

ACOUSTIC DROPLET EJECTION; ACOUSTIC TECHNOLOGY; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG RESEARCH; EC50; LIVER CELL; NONHUMAN; PROTEIN ANALYSIS; ACOUSTICS; COMPARATIVE STUDY; DEVICES; DRUG DEVELOPMENT; EVALUATION STUDY; MEDICAL TECHNOLOGY; PRECLINICAL STUDY; PROCEDURES; SOLUTION AND SOLUBILITY; STRUCTURE ACTIVITY RELATION; WORKFLOW;

ACOUSTICS; BIOMEDICAL TECHNOLOGY; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; SOLUTIONS; STRUCTURE-ACTIVITY RELATIONSHIP; WORKFLOW;

EID: 84955488932     PISSN: 22110682     EISSN: 22110690     Source Type: Journal    
DOI: 10.1177/2211068215587915     Document Type: Article

References (14)

1. S.A.SadryD.J.DruckerEmerging Combinatorial Hormone Therapies for the Treatment of Obesity and T2DM. Nat. Rev. Endocrinol. 2013, 9, 425–433.
2. J.E.CampbellD.J.DruckerPharmacology, Physiology, and Mechanisms of Incretin Hormone Action. Cell Metab. 2013, 17, 819–837.
3. J.W.DayN.OttawayJ.T.Patterson. A New Glucagon and GLP-1 Co-Agonist Eliminates Obesity in Rodents. Nat. Chem. Biol. 2009, 5, 749–757.
4. A.PocaiP.E.CarringtonJ.R.Adams. Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice. Diabetes2009, 58, 2258–2266.
5. M.E.DoyleJ.M.EganMechanisms of Action of Glucagon-Like Peptide 1 in the Pancreas. Pharmacol. Ther. 2007, 113, 546–593.
6. M.Goebel-StengelA.StengelY.Taché. The Importance of Using the Optimal Plasticware and Glassware in Studies Involving Peptides. Anal. Biochem. 2011, 414, 38–46.
7. R.J.GrantK.RobertsC.Pointon. Achieving Accurate Compound Concentration in Cell-Based Screening: Validation of Acoustic Droplet Ejection Technology. J. Biomol. Screen. 2009, 14, 452–459.
8. A.MerglenS.TheanderB.Rubi. Glucose Sensitivity and Metabolism-Secretion Coupling Studied during Two-Year Continuous Culture in INS-1E Insulinoma Cells. Endocrinology. 2004, 145, 667–678.
9. G.Da ViolanteN.ZerroukI.Richard. Evaluation of the Cytotoxicity Effect of Dimethyl Sulfoxide (DMSO) on Caco2/TC7 Colon Tumor Cell Cultures. Biol. Pharm. Bull. 2002, 25, 1600–1603.
10. E.S.OzE.AydemirK.FışkınDMSO Exhibits Similar Cytotoxicity Effects to Thalidomide in Mouse Breast Cancer Cells. Oncol. Lett. 2012, 3, 927–929.
11. D.KempJ.HabenerSynergistic Effect of Dimethyl Sulfoxide on Glucagon-Like Peptide 1 (GLP-1)–Stimulated Insulin Secretion and Gene Transcription in INS-1 Cells: Characterization and Implications. Biochem. Pharmacol. 2002, 64, 689–697.
12. P.B.WieserM.A.ZeigerJ.N.FainEffects of Dimethylsulfoxide on Cyclic AMP Accumulation, Lipolysis and Glucose Metabolism of Fat Cells. Biochem. Pharmacol. 1977, 26, 775–778.
13. K.MoensH.HeimbergD.Flamez. Expression and Functional Activity of Glucagon, Glucagon-Like Peptide I, and Glucose-Dependent Insulinotropic Peptide Receptors in Rat Pancreatic Islet Cells. Diabetes. 1996, 45, 257–261.
14. N.AbrahamsenK.LundgrenE.NishimuraRegulation of Glucagon Receptor mRNA in Cultured Primary Rat Hepatocytes by Glucose and cAMP. J. Biol. Chem. 1995, 270, 15853–15857.